Feedback / Questions
ondansetron ultra-low dose (AD04) - Adial
https://www.globenewswire.com/news-release/2025/05/08/3077273/26135/en/Adial-Pharmaceuticals-Granted-End-of-Phase-2-Meeting-from-the-U-S-Food-and-Drug-Administration.html
May 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next